Top

Graefe's Archive for Clinical and Experimental Ophthalmology

Published in:

13-11-2023 | Glaucoma | Glaucoma

Five-year outcomes of ab interno Xen 45 gel stent implantation

Author: Ejaz Ansari

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 4/2024

Abstract

Background

To assess the safety and 5-year efficacy of ab interno XEN 45 gel stent implantation with phacoemulsification in primary open-angle glaucoma (POAG).

Methods

Single-centre, single-surgeon, retrospective case note review of consecutive OAG patients who underwent ab-interno gel stent placement combined with phacoemulsification. Surgeries were performed between 2/01/2014 and 2/01/2016. Primary outcome measures: mean reduction in intraocular pressure (IOP) and change in number of ocular hypotensive medications from baseline (follow-up range 1–7 years; mean 54 months). Secondary outcome measure: change in visual field mean deviation (VFMD) from baseline. Safety data included intraoperative and post-operative complications and adverse events. Failure was defined by IOP reduction < 20% despite maximum medical therapy, the need for further laser or surgical intervention. At 5 years, 75% of eyes were free from failure (95% CI 64 to 83%).

Results

Ninety-one eyes were analysed. Mean (SD) IOP and medications decreased from 20.2 (6.4) mmHg and 2.9 (1.0) at baseline to 15.4 (3.6) mmHg (p < 0.001) and 1.5 (1.4) medications at 5 (p < 0.001) years. Baseline mean VFMD (SD) was − 10.3dB (8.5) reducing to − 10.9(8.2) (p < 0.01) at 5 years. Two (2%) eyes had intraoperative complications, 4 (4.3%) experienced post-operative AEs, and 13 (14%) required secondary surgical intervention (SSI).

Conclusion

The gel stent combined with phacoemulsification was effective in reducing IOP and medications over 5 years, with an acceptable safety profile. Visual field change was clinically acceptable through the study period.

American Academy of Ophthalmology (2015) Primary open-angle glaucoma—preferred practice pattern. http://www.aaojournal.org/article/S0161-6420(15)01276-2/pdf. Accessed 23 Nov 2021

European Glaucoma Society Terminology and guidelines for glaucoma (5th edition). https://www.eugs.org/eng/guidelines.asp. Accessed 3 Oct 2021

Lichter PR, Musch DC, Gillespie BW, Guire KE, Janz NK, Wren PA, Mills RP, CIGTS Study Group (2001) Interim clinical outcomes in the Collaborative Initial Glaucoma Treatment Study comparing initial treatment randomized to medications or surgery. Ophthalmology 108:1943–1953. https://doi.org/10.1016/S0161-6420(01)00873-9CrossRefPubMed

Feiner L, Piltz-Seymour JR (2003) Collaborative Initial Glaucoma Treatment Study: a summary of results to date. Curr Opin Ophthalmol 14:106–111CrossRefPubMed

Jampel HD, Musch DC, Gillespie BW, Lichter PR, Wright MM, Guire KE (2005) Perioperative complications of trabeculectomy in the collaborative initial glaucoma treatment study (CIGTS). Am J Ophthalmol 140:16–22. https://doi.org/10.1016/j.ajo.2005.02.013CrossRefPubMed

Zahid S, Musch DC, Niziol LM, Lichter PR (2013) Risk of endophthalmitis and other long-term complications of trabeculectomy in the Collaborative Initial Glaucoma Treatment Study (CIGTS). Am J Ophthalmol 155:674–680.e1. https://doi.org/10.1016/j.ajo.2012.10.017CrossRefPubMed

Gedde SJ, Feuer WJ, Shi W, Lim KS, Barton K, Goyal S, Ahmed IIK, Brandt J (2018) Treatment outcomes in the primary tube versus trabeculectomy study after 1 year of follow-up. Ophthalmology 125:650–663. https://doi.org/10.1016/j.ophtha.2018.02.003CrossRefPubMed

Vera VI, Horvath C (2014) XEN gel stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer Science+Business Media, New York, pp 189–198CrossRef

Samuelson TW, Katz LJ, Wells JM, Duh YJ, Giamporcaro JE (2011) Randomized evaluation of the trabecular micro-bypass stent with phacoemulsification in patients with glaucoma and cataract. Ophthalmology 118:459–467. https://doi.org/10.1016/j.ophtha.2010.07.007CrossRefPubMed

10.

Denis P, Hirneiß C, Durr GM et al (2022) Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol 106:65–70CrossRefPubMed

11.

Caprioli J, Kim JH, Friedman DS etal., (2015) Special commentary: supporting innovation for safe and effective minimally invasive glaucoma surgery: summary of a joint meeting of the American Glaucoma Society and the Food and Drug Administration, Washington, DC. Ophthalmology 122:1795–1801. https://doi.org/10.1016/j.ophtha.2015.02.029

12.

De Gregorio A, Pedrotti E, Russo L, Morselli S (2017) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest ab interno gel stent. Int Ophthalmol 38:1129–1134. https://doi.org/10.1007/s10792-017-0571-xCrossRefPubMed

13.

Galal A, Bilgic A, Eltanamly R, Osman A (2017) XEN glaucoma implant with mitomycin C 1-year follow-up: result and complications. J Ophthalmol:5457246. https://doi.org/10.1155/2017/5457246

14.

Hengerer FH, Kohnen T, Mueller M, Conrad-Hengerer I (2017) Ab interno gel implant for the treatment of glaucoma patients with or without prior glaucoma surgery: 1-year results. J Glaucoma 26:1130–1136. https://doi.org/10.1097/ijg.0000000000000803CrossRefPubMed

15.

Sng CC, Wang J, Hau S, Htoon HM, Barton K (2017) XEN-45 collagen implant for the treatment of uveitic glaucoma. Clin Exp Ophthalmol 46:339–334. https://doi.org/10.1111/ceo.13087CrossRefPubMed

16.

Mansouri K, Guidotti J, Rao HL, Ouabas A, D'Alessandro E, RoyS MA (2018) Prospective evaluation of standalone XEN gel implant and combined phacoemulsification-XEN Gel implant surgery: 1-year results. J Glaucoma 27:140–147. https://doi.org/10.1097/IJG.0000000000000858CrossRefPubMed

17.

Tan SZ, Walkden A, Au L (2018) One-year result of XEN45 implant for glaucoma: efficacy, safety, and postoperativemanagement. Eye 32:324–332. https://doi.org/10.1038/eye.2017.162CrossRefPubMed

18.

Gillmann K, Bravetti GE, Mermoud A, Rao HL, Mansouri K (2019) XEN Gel Stent in pseudoexfoliative glaucoma: 2-year results of a prospective evaluation. J Glaucoma 28:676–684CrossRefPubMed

19.

Reitsamer H, Sng C, Vera V, Lenzhofer M, Barton K, Stalmans I (2019) Two-year results of a multicenter study of the ab interno gelatin implant in medically uncontrolled primary open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 257:983–996CrossRefPubMed

20.

Gabbay IE, Allen F, Morley C et al (2020) Efficacy and safety data for the XEN45 implant at 2 years: a retrospective analysis. Br J Ophthalmol 104:1125–1130CrossRefPubMed

21.

Gillmann K, Bravetti GE, Rao HL et al (2020a) Combined and stand-alone XEN 45 gel stent implantation: 3-year outcomes and success predictors. Acta Ophthalmol. https://doi.org/10.1111/aos.14605

22.

Reitsamer H, Vera V, Ruben S et al (2021) Three-year effectiveness and safety of the XEN gel stent as a solo procedure or in combination with phacoemulsification in open-angle glaucoma: a multi-centre study. Acta Ophthalmol 100(1):e233–e245. https://doi.org/10.1111/aos.14886CrossRefPubMedPubMedCentral

23.

Kono Y, Kasahara M, Hirasawa K et al (2020) Long-term clinical results of trabectome surgery in patients with open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 258(11):2467–2476. https://doi.org/10.1007/s00417-020-04897-0CrossRefPubMed

24.

Ansari E (2021) 5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma. PloS One 16(9):e0257015. https://doi.org/10.1371/journal.pone.0257015CrossRefPubMedPubMedCentral

25.

Ziaei H, Au L (2021) Manchester iStent study: long-term 7-year outcomes. Eye 35:2277–2282CrossRefPubMed

26.

Ahmed IIK, De Francesco T, Rhee D et al (2022) HORIZON Investigators. Long-term outcomes from the HORIZON randomized trial for a Schlemm’s canal microstent in combination cataract and glaucoma surgery. Ophthalmol 7:742–751. https://doi.org/10.1016/j.ophtha.2022.02.021CrossRef

Title: Five-year outcomes of ab interno Xen 45 gel stent implantation
Author: Ejaz Ansari
Publication date: 13-11-2023
Publisher: Springer Berlin Heidelberg
Keyword: Glaucoma
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 4/2024
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI: https://doi.org/10.1007/s00417-023-06294-9

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Five-year outcomes of ab interno Xen 45 gel stent implantation

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2024

Comparison of different corneal imaging modalities using artificial intelligence for diagnosis of keratoconus: a systematic review and meta-analysis

170 years of data-mining: history and future

Editorial: Expanded insights into diabetic neovascular glaucoma by widefield swept-source optical coherence tomography angiography

Acute dacryocystitis: changing practice pattern over the last three decades at a tertiary care setup

Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study

The temporal trends in association between newer medications and diabetic retinopathy